logo

BEAM

Beam TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

BEAM Profile

Beam Therapeutics Inc.

A company that developing DNA base editing and gene editing technologies

Biological Technology
01/25/2017
02/06/2020
NASDAQ Stock Exchange
483
12-31
Common stock
238 Main Street, Cambridge, MA 02142
--
Founded on January 25, 2017, Beam Therapeutics Inc., is a biotechnology company dedicated to creating a new class of precision genetic medicines based on its proprietary base editing technology, with the vision of providing lifelong treatment for patients suffering from serious diseases.